Opportunity remains despite regulatory and access obstacles.
Karina Ikeda
Advertisement
Karina Ikeda is a senior consultant within the life sciences practice at Guidehouse
Articles by Karina Ikeda
Advertisement
Latest Updated Articles
The JAKs Journey Offers Valuable Lessons for InnovatorsFebruary 17th 2022
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
3
Cautious Momentum: Biopharma Review and Outlook
4
Moving CAR-T Beyond Oncology
5